Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1 | 2 | 1 | 1 | 0 |
| Gross Profit | 1 | 2 | 1 | 1 | 0 |
| Operating Expenses | 1,559 | 1,626 | 977 | 685 | 727 |
| Operating Income | -1,558 | -1,624 | -976 | -684 | -727 |
| Interest Expense | 2 | 1,237 | 897 | 399 | 0 |
| Other Income | 39 | 1,186 | -3,047 | 995 | -743 |
| Pre-tax Income | -1,521 | -1,675 | -4,919 | -88 | -1,470 |
| Income Tax | 12 | 0 | 0 | 0 | 2 |
| Net Income Continuous | -1,533 | -1,675 | -4,920 | -88 | -1,472 |
| Net Income | $-1,533 | $-1,675 | $-4,920 | $-88 | $-1,472 |
| EPS Basic Total Ops | -5.41 | -1.80 | -35.14 | -0.90 | -16.52 |
| EPS Basic Continuous Ops | -5.46 | -1.82 | -35.14 | -0.98 | -16.49 |
| EPS Diluted Total Ops | -5.41 | -1.80 | -35.14 | -0.90 | -16.52 |
| EPS Diluted Continuous Ops | -5.46 | -1.82 | -35.14 | -0.98 | -16.49 |
| EBITDA(a) | $-1,536 | $-1,534 | $-208 | $-456 | $252 |